Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy.
Spallarossa P, Sarocchi M, Tini G, Arboscello E, Toma M, Ameri P, Porto I. Spallarossa P, et al. Among authors: arboscello e. Front Pharmacol. 2020 Jun 26;11:972. doi: 10.3389/fphar.2020.00972. eCollection 2020. Front Pharmacol. 2020. PMID: 32676031 Free PMC article. Review.
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion.
Breccia M, Pregno P, Spallarossa P, Arboscello E, Ciceri F, Giorgi M, Grossi A, Mallardo M, Nodari S, Ottolini S, Sala C, Tortorella G, Rosti G, Pane F, Minotti G, Baccarani M. Breccia M, et al. Among authors: arboscello e. Ann Hematol. 2017 Apr;96(4):549-558. doi: 10.1007/s00277-016-2820-x. Epub 2016 Sep 30. Ann Hematol. 2017. PMID: 27686083 Review.
Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontline.
Breccia M, Arboscello E, Bellodi A, Colafigli G, Molica M, Bergamaschi M, Massaro F, Quattrocchi L, Sarocchi M, Spallarossa P, Alimena G. Breccia M, et al. Among authors: arboscello e. Crit Rev Oncol Hematol. 2016 Nov;107:190-198. doi: 10.1016/j.critrevonc.2016.10.002. Epub 2016 Oct 15. Crit Rev Oncol Hematol. 2016. PMID: 27823647 Review.
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation.
Bauckneht M, Ferrarazzo G, Fiz F, Morbelli S, Sarocchi M, Pastorino F, Ghidella A, Pomposelli E, Miglino M, Ameri P, Emionite L, Ticconi F, Arboscello E, Buschiazzo A, Massimelli EA, Fiordoro S, Borra A, Cossu V, Bozzano A, Ibatici A, Ponzoni M, Spallarossa P, Gallamini A, Bruzzi P, Sambuceti G, Marini C. Bauckneht M, et al. Among authors: arboscello e. J Nucl Med. 2017 Oct;58(10):1638-1645. doi: 10.2967/jnumed.117.191122. Epub 2017 Jun 23. J Nucl Med. 2017. PMID: 28646013 Free article.
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility.
Bauckneht M, Morbelli S, Fiz F, Ferrarazzo G, Piva R, Nieri A, Sarocchi M, Spallarossa P, Canepari ME, Arboscello E, Bellodi A, Massaia M, Gallamini A, Bruzzi P, Marini C, Sambuceti G. Bauckneht M, et al. Among authors: arboscello e. Diagnostics (Basel). 2017 Oct 26;7(4):57. doi: 10.3390/diagnostics7040057. Diagnostics (Basel). 2017. PMID: 29072629 Free PMC article.
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.
Spallarossa P, Meliota G, Brunelli C, Arboscello E, Ameri P, Dessalvi CC, Grossi F, Deidda M, Mele D, Sarocchi M, Bellodi A, Madonna R, Mercuro G. Spallarossa P, et al. Among authors: arboscello e. Med Res Rev. 2018 Sep;38(5):1447-1468. doi: 10.1002/med.21478. Epub 2017 Dec 28. Med Res Rev. 2018. PMID: 29283446 Review.
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.
Cavo A, Rubagotti A, Zanardi E, Fabbroni C, Zinoli L, Di Meglio A, Arboscello E, Bellodi A, Spallarossa P, Cattrini C, Messina C, Boccardo F. Cavo A, et al. Among authors: arboscello e. Ther Adv Med Oncol. 2018 Jan 9;10:1758834017745819. doi: 10.1177/1758834017745819. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29383035 Free PMC article.
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Sarocchi M, Grossi F, Arboscello E, Bellodi A, Genova C, Dal Bello MG, Rijavec E, Barletta G, Rossi G, Biello F, Ghigliotti G, Canepa M, Mussap M, Brunelli C, Spallarossa P. Sarocchi M, et al. Among authors: arboscello e. Oncologist. 2018 Aug;23(8):936-942. doi: 10.1634/theoncologist.2017-0452. Epub 2018 Mar 22. Oncologist. 2018. PMID: 29567824 Free PMC article.
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
Sarocchi M, Bauckneht M, Arboscello E, Capitanio S, Marini C, Morbelli S, Miglino M, Congiu AG, Ghigliotti G, Balbi M, Brunelli C, Sambuceti G, Ameri P, Spallarossa P. Sarocchi M, et al. Among authors: arboscello e. J Transl Med. 2018 Oct 25;16(1):295. doi: 10.1186/s12967-018-1670-9. J Transl Med. 2018. PMID: 30359253 Free PMC article.
52 results